Aleen Inc. – 2025: A Year of Insight, Clarity, and Growth 
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
REHOVOT, Israel, Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company,...
SmartLabs and Sonrai Launch Exclusive Partnership to Bring Advanced AI Capabilities to SmartLabs’ Member Companies
Strategic Partnership Agreement Integrates Sonrai's AI Data Management Platform, Sonrai Discovery, with SmartLabs' Advanced Laboratory Infrastructure BOSTON, Aug. 28, 2025 /PRNewswire/ -- SmartLabs and...
New Technology Offers Solution To Plastic Waste Threat:Plastic 2 Green Achieves Breakthrough in Nitrogen-Doped Graphene Production and Receives First Purchase Order
LOVELAND, Colo., Aug. 28, 2025 /PRNewswire/ -- A promising breakthrough in converting waste plastic—one of humankind's largest environmental threats—into high-value...
Five Mothers Unite in First-Ever Collaboration to Fund $1.5 Million Groundbreaking Ewing Sarcoma Grant
Los Angeles, California--(Newsfile Corp. - August 28, 2025) - In a powerful act of unity and determination, five mothers—each having...
Adia Nutrition Joins PI Doctors Elite Community as Preferred Vendor Unlocking Access to a $50 Billion Personal Injury Care Market
Winter Park, Florida--(Newsfile Corp. - August 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on...
CASI Pharmaceuticals to Participate at Cantor Global Healthcare Conference 2025
SAN FRANCISCO, CA / ACCESS Newswire / August 28, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused...
Phase 1 Equity Announces It’s Sixth Practice Addition Of The Year, Bringing On A Multi-Site, Multi-Doctor Orthodontic Practice Located in Ohio
CHICAGO, IL / ACCESS Newswire / August 28, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for...
Black Book Research Unveils First Pan-European Study of EHDS Interoperability Vendors as Hospitals Brace for 2026 Compliance Deadline
Independent Benchmarking Across 13 EU Countries and the UK Reveals Vendor Readiness and Country Gaps Ahead of EHDS Enforcement LONDON,...
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives...
UniDoc Health Corp. Provides Corporate Update
VANCOUVER, BC / ACCESS Newswire / August 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or "the Company") pleased to...
Can-Fite Reports H1 2025 Financial Results and Clinical Update
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company...
The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025
STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International...
PolarityBio to Share Regenerative Wound Healing Expertise at SAWC Fall 2025
SALT LAKE CITY, Aug. 28, 2025 (GLOBE NEWSWIRE) -- PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in...
CorMedix to Participate in Upcoming Investor Conferences
BERKELEY HEIGHTS, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing...
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1×1 Conference on September 4th
LOS ANGELES, CA & VANCOUVER, BC , Aug. 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”),...
CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
VANCOUVER, Washington, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing...
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in...